Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks

Clinical trial NCT03122132 · COMPLETED

Trial details

NCT number: NCT03122132
Sponsor: Hepa C
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis C Infection

Start date: 2017-02-20
Primary completion: 2018-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.